S. Rowell

Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma

N. Munshi, P. Richardson, T. Hideshima, 2021, Leukemia.

Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy

M. Dimopoulos, N. Bolli, P. Richardson, 2021, Blood Cancer Journal.

AB0665 Apparent Late TNFI Secondary Treatment Failure in Axial Spondyloarthritis

K. Gaffney, R. Sengupta, A. Keat, 2014 .

Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs

Yongjin Sung, W. Choi, Z. Yaqoob, 2022, bioRxiv.